Position in ONC
as of Mar 31, 2026
· filed Apr 10, 2026
Position Value
$753,412
-$5,505 QoQ
Shares Held
2,537
+1.6% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2025
5 quarters on record
Voting authority
Sole 1.5372487189594009.ToString("F0")%
Shared 0.ToString("F0")%
None 98.4627512810406.ToString("F0")%
Common Shares in ONC Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Perigon Wealth Management, LLC holds $14,925,800 across 15 Biotechnology names. ONC ranks #5 (5.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
7,680 | $5,933,875 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
6,454 | $2,881,969 | |
| 3 | FDMT |
4D Molecular Therapeutics, Inc.
|
146,197 | $1,361,094 | |
| 4 | CRSP |
CRISPR Therapeutics AG
|
20,066 | $954,539 | |
| 5 | ONC |
BeOne Medicines Ltd.
This page
|
2,537 | $753,412 | |
| 6 | VERA |
Vera Therapeutics, Inc.
|
14,976 | $602,484 | |
| 7 | BNTX |
BioNTech SE
|
5,837 | $518,792 | |
| 8 | INCY |
Incyte Corp
|
3,875 | $364,715 |
All Filings in ONC
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $753,412 | 2,537 | Shares | Sole | 2026-04-10 | |
| 2025-12-31 | $758,917 | 2,498 | Shares | Sole | 2026-01-16 | |
| 2025-09-30 | $807,799 | 2,371 | Shares | Sole | 2025-10-17 | |
| 2025-06-30 | $580,968 | 2,400 | Shares | Sole | 2025-07-16 | |
| 2025-03-31 | $647,492 | 2,379 | Shares | Sole | 2025-04-23 | |
| No filing history on record for this holder in this stock. | ||||||